Research News and Research

RSS

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Low levels of the anti-aging hormone Klotho may serve as an early warning sign of the presence of kidney disease and its deadly cardiovascular complications, according to findings by UT Southwestern Medical Center researchers.

18 Feb 2011

Scientists integrate multimedia patient data into PDF document

Who wouldn't want to send his heartbeat electronically? Not only scientists and doctors, but also lovers can now indulge in this desire. Researchers at the Charité - Universitätsmedizin Berlin, in collaboration with colleagues at the university hospitals of Jena and Münster, the Bundeswehrkrankenhaus Berlin and the Erlangen-based company 3D-Shape GmbH have, for the first time, embedded multimedia patient data into an electronic publication.

18 Feb 2011

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.

18 Feb 2011

Medical expert speaks about effects of sugar on human body

With the many forms of sugar available, from table sugar, to high-fructose corn syrup to agave and honey, understanding the differences between sugars and their effects on the body is not all sweet.

18 Feb 2011

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, announced today that the global phase 3 studies with TMC435 in treatment-naive patients and patients who have relapsed after prior SOC treatment have started.

18 Feb 2011

Commentary examines current guidelines for cancer survivors, suggests future nutrition research

Cancer survivors die of non-cancer-related causes at much higher rates than the general public. In 2008, the U.S. economic burden of cancer totaled over $228 billion but only 41% of these costs involved direct cancer care. The majority of expenses were attributed to increased morbidity, lost productivity, and premature mortality.

18 Feb 2011

Canadian experts to discuss on latest developments in speech research at AASS

Three leading Canadian language and speech experts will take centre stage in discussions on the latest developments in speech research at this year's annual meeting of the American Association for the Advancement of Science in Washington, D.C.

18 Feb 2011

Scientists establish biomarker strategy to diagnose variety of cancer types

A team of biologists, clinical oncologists, pathologists and information scientists has established a strategy for identifying biomarkers. If a particular pattern of these biomarkers can be detected in the blood, this indicates a cancerous disease. An interdisciplinary research breakthrough that opens many doors.

18 Feb 2011

Emotional response to challenging situations predict body's response to stress

Your emotional response to challenging situations could predict how your body responds to stress, according to research published this month in the journal Brain, Behavior, and Immunity.

18 Feb 2011

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.

18 Feb 2011

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.

18 Feb 2011

U.N.-backed meeting in Bangkok will examine how legal barriers in Asia hamper fight against HIV/AIDS

"Legal barriers are obstructing the fight against HIV/AIDS in the Asia, where 19 nations outlaw same-sex relations and 29 countries criminalize prostitution, United Nations experts said Wednesday," on the eve of the Global Commission of HIV and the Law meeting in Bangkok, Deutsche Presse-Agentur/M&C reports.

18 Feb 2011

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

Researchers at the University of Pittsburgh have been awarded funding for two projects that will place brain-computer interfaces (BCI) in patients with spinal cord injuries to test if it is possible for them to control external devices, such as a computer cursor or a prosthetic limb, with their thoughts.

18 Feb 2011

Legislation to repeal health law's 1099 reporting requirement would cut premium tax credits

The Republican majority in the House, with President Obama's support, plans to scale back health care subsidies for the uninsured in order to pay for eliminating the "burdensome" requirement that small businesses file 1099 forms with the Internal Revenue Service when contractors are paid over $600.

18 Feb 2011

TI Pharma launches new research project on stem cell transplant

Top Institute Pharma is today launching a new research project that should make stem cell transplants more successful. A stem cell transplant is usually performed on adults with acute leukemia.

18 Feb 2011

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

In the wake of President Barack Obama's fiscal year 2012 budget proposal and the negotiation of the fiscal year 2011 budget bill in the House of Representatives, news outlets looked at stakeholders' responses to the measures and analyzed different pieces of the bills.

18 Feb 2011

AHRQ: Low-income rural Americans with COPD more likely to be hospitalized

Low-income Americans with chronic obstructive pulmonary disease and those who lived in rural areas or the South or Midwest in 2008 had the highest rates of hospitalization for symptoms of the disease, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Feb 2011

UNC, Cleveland Clinic choose Carefx Physician Insight Plus tool for performance improvement

Carefx Corp., a leading provider of interoperable workflow solutions, announced today that the University of North Carolina Hospitals has chosen Fusionfx Physician Insight Plus™, one of many performance improvement dashboards offered by Carefx and developed in collaboration with Cleveland Clinic.

18 Feb 2011

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.

18 Feb 2011

Daily Report Global Health Conversations: Global health funding and the FY11, FY12 budgets

As Congress considers both the FY11 and FY12 budgets, the Kaiser Daily Global Health Policy Report's Jaclyn Schiff spoke to Adam Wexler, a senior policy analyst for global health policy at the Kaiser Family Foundation, about the potential implications for global health funding.

18 Feb 2011

Research News and Research

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Scientists integrate multimedia patient data into PDF document

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Medical expert speaks about effects of sugar on human body

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

Commentary examines current guidelines for cancer survivors, suggests future nutrition research

Canadian experts to discuss on latest developments in speech research at AASS

Scientists establish biomarker strategy to diagnose variety of cancer types

Emotional response to challenging situations predict body's response to stress

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

U.N.-backed meeting in Bangkok will examine how legal barriers in Asia hamper fight against HIV/AIDS

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

Legislation to repeal health law's 1099 reporting requirement would cut premium tax credits

TI Pharma launches new research project on stem cell transplant

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

AHRQ: Low-income rural Americans with COPD more likely to be hospitalized

UNC, Cleveland Clinic choose Carefx Physician Insight Plus tool for performance improvement

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Daily Report Global Health Conversations: Global health funding and the FY11, FY12 budgets

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology